Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-25-010060
Filing Date
2025-07-03
Accepted
2025-07-03 18:00:10
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-70061.html 4  
1 PRIMARY DOCUMENT marketforms-70061.xml 4 3484
  Complete submission text file 0001214659-25-010060.txt   4992
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Issuer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1951 NW 7TH AVENUE MIAMI FL 33136
Business Address
Agafonova Nataliya (Reporting) CIK: 0001985443 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40060 | Film No.: 251106559